Sort
16,300 grants matching “fatty liver disease”
Cancer Control Program
$26,444Jacqueline Kerr · University Of California, San Diego · P30 · FY2022 · CA
Neutral sphingomyelinase-2 and glucocorticoid receptor
$26,415Mariana Nikolova-Karakashian · University Of Kentucky · R01 · FY2021 · AG
HEPATIC FATTY ACID METABOLISM AND STEATOSIS
$26,360Nicholas Davidson · Washington University · R01 · FY2011 · DK
Steroid Receptor Coactivator-2 as a key hepatic tumor suppressor and circadian me
$26,232Erin Stashi · Baylor College Of Medicine · F31 · FY2012 · CA
Hepatic Rictor Knockout Mouse Model and the Metabolic Syndrome
$26,160Jennifer Marie Rojas · Vanderbilt University · F31 · FY2011 · DK
Hepatic Estrogen Signaling and Protection Against Insulin Resistance
$26,160Melissa Nicole Martinez · Vanderbilt University · F31 · FY2011 · DK
CEST AND MAGNETIC TRANSFER MRI OF LIVER FIBROSIS
$26,016Kewen Cai · University Of Pennsylvania · P41 · FY2010 · RR
COMPASSIONATE USE OF AN INTRAVENOUS FAT EMULSION COMPRISED OF FSIH OIL IN THE TR
$25,942Steven A Abrams · Baylor College Of Medicine · M01 · FY2011 · RR
The Role of ERRa in liver lipid dysfunction and pathology
$25,878Bangyan Stiles · University Of Southern California · R01 · FY2023 · DK
EFFECT OF AMINO ACID INTAKE ON VLDL TURNOVER
$25,834Elisabet Boersheim · University Of Texas Med Br Galveston · M01 · FY2008 · RR
ROLE OF PIOGLITAZONE IN THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS
$25,767Kenneth Cusi · University Of Texas Hlth Science Center · M01 · FY2007 · RR
Hepatic Rictor Knockout Mouse Model and the Metabolic Syndrome
$25,740Jennifer Marie Rojas · Vanderbilt University · F31 · FY2010 · DK
PREDICTORS OF HISTOLOGIC SEVERITY IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
$25,733University Of Michigan At Ann Arbor · M01 · FY2005 · RR
wnt Signaling in Liver Development and Disease
$25,717Wolfram Goessling · Massachusetts General Hospital · K08 · FY2008 · DK
Endothelin in obesity induced insulin resistanceInvestigate the effects of the endothelin receptor type B in visceral adipose and mechanisms by which it can drive insulin resistance in obesi
$25,704Osvaldo Rivera Gonzalez · University Of Mississippi Med Ctr · F31 · FY2020 · DK
Effect of impaired macrophage autophagy on the development of fatty liver disease
$25,573Kun Liu · Albert Einstein College Of Medicine · F32 · FY2014 · DK
Molecular Drivers of FABP-mediated Endocannabinoid Signaling for Appetite Regulation
$25,374Ruth E. Stark · City College Of New York · R16 · FY2024 · GM
Acetaldehyde Effect on Protein-Adduct Formation and GI Tract Substrate Transport
$25,284Scott J Fisher · University Of Maryland Baltimore · F31 · FY2007 · AA
Treatment of breast cancer tumor growth and metastasis with an anti-MMP-9 DNAzyme
$25,176Miranda Alvina Marie Hallett · University Of Tennessee Health Sci Ctr · F31 · FY2009 · CA
Mechanisms of high fat diet-induced circadian hepatic transcription and lipid metabolism reprogramming
$25,077Dongyin Guan · University Of Pennsylvania · F32 · FY2020 · DK
CEACAM and Insulin Action
$25,000Sonia Michael Najjar · Ohio University Athens · R01 · FY2014 · DK
13th International Copper Meeting: From Mechanisms to Therapy
$25,000Donita C Brady · University Of Pennsylvania · R13 · FY2024 · TR
FASEB's "The Liver Biology Conference: Fundamental Mechanisms and Translational Applications"
$25,000Stacey S Huppert · Federation Of Amer Soc For Exper Biology · R13 · FY2020 · DK
Understanding and Addressing Cancer Health Disparities in Louisiana
$25,000Augusto C Ochoa · Lsu Health Sciences Center · P20 · FY2019 · CA
A High Throughput Imaging Assay for Hepatic Lipid Droplet Formation
$24,998Patrick M McDonough · Vala Sciences, Inc. · R03 · FY2008 · DA